Sugiyama, T <br/><br/>
Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.  [electronic resource] 

 -  Gene therapy  Mar 2013 
 - 338-47 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5462 
<br/><br/><label>Standard No.: </label>10.1038/gt.2012.44  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD--genetics<br/>Breast Neoplasms--genetics<br/>CHO Cells<br/>Cell Adhesion Molecules--genetics<br/>Cell Line<br/>Cell Line, Tumor<br/>Chlorocebus aethiops<br/>Cricetinae<br/>Cricetulus<br/>Female<br/>HEK293 Cells<br/>Humans<br/>MCF-7 Cells<br/>Macaca fascicularis<br/>Macaca mulatta<br/>Measles virus--genetics<br/>Membrane Cofactor Protein--genetics<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Oncolytic Virotherapy--methods<br/>Oncolytic Viruses--genetics<br/>Receptors, Cell Surface--genetics<br/>Signaling Lymphocytic Activation Molecule Family Member 1<br/>Vero Cells<br/>Xenograft Model Antitumor Assays